Order reprints

Open Access Highly Accessed

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

Daniel R Murphy*, Lee J Smolen, Timothy M Klein and Robert W Klein

  • * Corresponding author: Daniel R Murphy drm@mdm-inc.com

  • † Equal contributors

BMC Musculoskeletal Disorders 2012, 13:213  doi:10.1186/1471-2474-13-213

This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.

Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.

Fields marked * are required

http://www.biomedcentral.com/1471-2474/13/213
1471-2474-13-213